209 related articles for article (PubMed ID: 2378090)
21. [A semisynthetic flavonoid from the Baikal skullcap (Scutellaria baicalensis) as an agent to enhance the efficacy of chemotherapy in experimental tumors].
Razina TG; Zueva EP; Litvinenko VI; Kovalev IP
Eksp Klin Farmakol; 1998; 61(2):54-6. PubMed ID: 9621177
[No Abstract] [Full Text] [Related]
22. [The pharmacological properties of preparations from the aziridinyl triazine group].
Stukov AN; Filov VA; Kon'kov SA; Ivin BA
Eksp Klin Farmakol; 1996; 59(1):58-60. PubMed ID: 8704637
[TBL] [Abstract][Full Text] [Related]
23. [Antitumor activity of thevetoside alone and in combination with chlormethine in vivo].
Zhang XW; Huang ZQ; Li CC
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):285-8. PubMed ID: 7976390
[TBL] [Abstract][Full Text] [Related]
24. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
Walker EM; Gale GR
Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
[No Abstract] [Full Text] [Related]
25. Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.
Noso Y; Niimi K; Nishiyama M; Hirabayashi N; Toge T; Niimoto M; Hattori T
Cancer Res; 1987 Dec; 47(23):6418-22. PubMed ID: 3677085
[TBL] [Abstract][Full Text] [Related]
26. [Experimental study of the antitumor properties and mechanism of action of kortifen].
Lagova ND; Kiselev VI; Kurdiumova KN; Sof'ina ZP; Shkodinskaia EN
Vopr Onkol; 1989; 35(4):450-6. PubMed ID: 2728387
[TBL] [Abstract][Full Text] [Related]
27. [Modulation of the antitumor effect of cyclophosphamide by the recombinant probiotic Subalin].
Cherdyntseva NV; Litviakov NV; Smol'ianinov ES; Beliavskaia VA; Masycheva VI
Vopr Onkol; 1997; 43(3):313-6. PubMed ID: 9245089
[TBL] [Abstract][Full Text] [Related]
28. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
[TBL] [Abstract][Full Text] [Related]
29. [The genetic correction of the mutagenic properties of fotrin by using the interferon inducer larifan in spontaneously metastasizing Lewis lung carcinoma].
Zolotareva GN; Loginova NS; Luchinova IM; Kinzirskiĭ AS
Vopr Onkol; 1993; 39(4-6):196-202. PubMed ID: 7975396
[No Abstract] [Full Text] [Related]
30. [The potential for enhancing the therapeutic efficacy of antitumor preparations].
Konovalova NP; Volkova LM; Klochko AV
Izv Akad Nauk SSSR Biol; 1989; (3):466-8. PubMed ID: 2760333
[TBL] [Abstract][Full Text] [Related]
31. Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.
Sadzuka Y; Sugiyama T; Suzuki H; Sawanishi H; Miyamoto K
Toxicol Lett; 2004 May; 150(3):341-9. PubMed ID: 15110086
[TBL] [Abstract][Full Text] [Related]
32. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
Nowak C; Arnold W; Henneberger G; Tanneberger S
Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
[TBL] [Abstract][Full Text] [Related]
33. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
[No Abstract] [Full Text] [Related]
34. [Experimental toxicologic and therapeutic studies on the activity of the CMF(cyclophosphamide-methotrexate-5-fluorouracil) scheme versus the VMF(vincristine-methotrexate-5-fluorouracil) scheme].
Berger MR; Habs M; Schmähl D
Arch Geschwulstforsch; 1984; 54(4):263-78. PubMed ID: 6548622
[TBL] [Abstract][Full Text] [Related]
35. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
[TBL] [Abstract][Full Text] [Related]
36. G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.
Leonetti C; Scarsella M; Riggio G; Rizzo A; Salvati E; D'Incalci M; Staszewsky L; Frapolli R; Stevens MF; Stoppacciaro A; Mottolese M; Antoniani B; Gilson E; Zupi G; Biroccio A
Clin Cancer Res; 2008 Nov; 14(22):7284-91. PubMed ID: 19010844
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals.
Tarnowski GS; Schmid FA; Cappuccino JG; Stock CC
Cancer Res; 1966 Mar; 26(3 Pt 2):181-206. PubMed ID: 4223040
[No Abstract] [Full Text] [Related]
38. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
[TBL] [Abstract][Full Text] [Related]
40. Substances with antineoplastic activity. XCVI. Some pharmacological properties and therapeutic synergism of 6-purinyl-N-(2-chloroethyl)thiocarbamate with cytosine arabinoside.
Mĕlka M; Krepelka J; Miko M; Pokorná S; Kejhová I; Reichlová R; Beitová M; Grimová J; Kargerová A; Sedivá J
Neoplasma; 1989; 36(4):419-25. PubMed ID: 2671756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
